These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3190995)

  • 21. Bioavailability of intramuscularly administered tenoxicam.
    Stebler T; Guentert TW
    Biopharm Drug Dispos; 1993 Aug; 14(6):483-90. PubMed ID: 8218966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians.
    Vianna-Jorge R; Perini JA; Rondinelli E; Suarez-Kurtz G
    Clin Pharmacol Ther; 2004 Jul; 76(1):18-26. PubMed ID: 15229460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
    Benveniste C; Striberni R; Dayer P
    Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenoxicam pharmacokinetics in rats: a population model.
    Troconiz IF; Lopez-Bustamante LG; Fos D
    J Pharm Sci; 1995 Dec; 84(12):1482-7. PubMed ID: 8748332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview on the pharmacokinetics of tenoxicam.
    Guentert TW; Heintz RC; Joly R
    Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal delivery of tenoxicam in rat.
    Raghavan CV; Abimon VD
    Int J Pharm; 2001 Jun; 221(1-2):227-9. PubMed ID: 11397584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of food and various antacids on the absorption of tenoxicam.
    Day RO; Lam S; Paull P; Wade D
    Br J Clin Pharmacol; 1987 Sep; 24(3):323-8. PubMed ID: 3499163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.
    Crevoisier C; Zaugg PY; Heizmann P; Meyer J
    Int J Clin Pharmacol Res; 1989; 9(5):327-34. PubMed ID: 2625372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of uraemia and anephric state on the pharmacokinetics of tenoxicam in the rat.
    Lopez-Bustamante LG; Troconiz JI; Fos D
    J Pharm Pharmacol; 1992 Nov; 44(11):898-901. PubMed ID: 1361533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the possible interaction between tenoxicam and furosemide.
    Hartmann D; Kleinbloesem CH; Lücker PW; Vetter G
    Arzneimittelforschung; 1987 Sep; 37(9):1072-6. PubMed ID: 3501723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iontophoresis of tenoxicam in the therapy of osteoarthrosis].
    Puccetti G; Galassi A; Gigli P; Pierallini FM; Pieraccini A; Scalabrino A
    Clin Ter; 1992 Mar; 140(3):239-42. PubMed ID: 1568367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.
    Hartmann D; Korn A; Komjati M; Heinz G; Haefelfinger P; Defoin R; Waldhäusl WK
    Br J Clin Pharmacol; 1990 Aug; 30(2):245-52. PubMed ID: 2119677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of tenoxicam in patients with impaired renal function.
    Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
    Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zomepirac--aspirin interactions in man.
    Desiraju RK; Nayak RK; Pritchard JF
    J Clin Pharmacol; 1984; 24(8-9):371-80. PubMed ID: 6480878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
    Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral tenoxicam for peripheral orthopaedic surgery: a pharmacokinetic study.
    Blake DW; Bjorksten AR; Libreri FC
    Anaesth Intensive Care; 1997 Apr; 25(2):142-6. PubMed ID: 9127656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of piroxicam, tenoxicam and their metabolites in equine urine by electrospray ionisation ion trap mass spectrometry.
    McKinney AR; Suann CJ; Stenhouse AM
    Rapid Commun Mass Spectrom; 2004; 18(19):2338-42. PubMed ID: 15384156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.